Literature DB >> 36268369

Recently FDA-approved drug: A new hope for vitiligo patients?

Mohammad Arham Siddiq1, Muhammad Adil Obaid1, Syeda Dua E Zehra Zaidi1, Syed Talal Azam1, Burhanuddin Rangwala1.   

Abstract

Entities:  

Year:  2022        PMID： 36268369      PMCID： PMC9577636          DOI： 10.1016/j.amsu.2022.104626

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN： 2049-0801


× No keyword cloud information.
  2 in total

Review 1.  Phototherapy for Vitiligo.

Authors:  Raheel Zubair; Iltefat H Hamzavi
Journal:  Dermatol Clin       Date:  2019-10-18       Impact factor: 3.478

Review 2.  Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.

Authors:  Fei Qi; Fang Liu; Ling Gao
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.